UniProt ID | PREX2_HUMAN | |
---|---|---|
UniProt AC | Q70Z35 | |
Protein Name | Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein | |
Gene Name | PREX2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1606 | |
Subcellular Localization | ||
Protein Description | Functions as a RAC1 guanine nucleotide exchange factor (GEF), activating Rac proteins by exchanging bound GDP for free GTP. Its activity is synergistically activated by phosphatidylinositol 3,4,5-trisphosphate and the beta gamma subunits of heterotrimeric G protein. Mediates the activation of RAC1 in a PI3K-dependent manner. May be an important mediator of Rac signaling, acting directly downstream of both G protein-coupled receptors and phosphoinositide 3-kinase.. | |
Protein Sequence | MSEDSRGDSRAESAKDLEKQLRLRVCVLSELQKTERDYVGTLEFLVSAFLHRMNQCAASKVDKNVTEETVKMLFSNIEDILAVHKEFLKVVEECLHPEPNAQQEVGTCFLHFKDKFRIYDEYCSNHEKAQKLLLELNKIRTIRTFLLNCMLLGGRKNTDVPLEGYLVTPIQRICKYPLILKELLKRTPRKHSDYAAVMEALQAMKAVCSNINEAKRQMEKLEVLEEWQSHIEGWEGSNITDTCTEMLMCGVLLKISSGNIQERVFFLFDNLLVYCKRKHRRLKNSKASTDGHRYLFRGRINTEVMEVENVDDGTADFHSSGHIVVNGWKIHNTAKNKWFVCMAKTPEEKHEWFEAILKERERRKGLKLGMEQDTWVMISEQGEKLYKMMCRQGNLIKDRKRKLTTFPKCFLGSEFVSWLLEIGEIHRPEEGVHLGQALLENGIIHHVTDKHQFKPEQMLYRFRYDDGTFYPRNEMQDVISKGVRLYCRLHSLFTPVIRDKDYHLRTYKSVVMANKLIDWLIAQGDCRTREEAMIFGVGLCDNGFMHHVLEKSEFKDEPLLFRFFSDEEMEGSNMKHRLMKHDLKVVENVIAKSLLIKSNEGSYGFGLEDKNKVPIIKLVEKGSNAEMAGMEVGKKIFAINGDLVFMRPFNEVDCFLKSCLNSRKPLRVLVSTKPRETVKIPDSADGLGFQIRGFGPSVVHAVGRGTVAAAAGLHPGQCIIKVNGINVSKETHASVIAHVTACRKYRRPTKQDSIQWVYNSIESAQEDLQKSHSKPPGDEAGDAFDCKVEEVIDKFNTMAIIDGKKEHVSLTVDNVHLEYGVVYEYDSTAGIKCNVVEKMIEPKGFFSLTAKILEALAKSDEHFVQNCTSLNSLNEVIPTDLQSKFSALCSERIEHLCQRISSYKKFSRVLKNRAWPTFKQAKSKISPLHSSDFCPTNCHVNVMEVSYPKTSTSLGSAFGVQLDSRKHNSHDKENKSSEQGKLSPMVYIQHTITTMAAPSGLSLGQQDGHGLRYLLKEEDLETQDIYQKLLGKLQTALKEVEMCVCQIDDLLSSITYSPKLERKTSEGIIPTDSDNEKGERNSKRVCFNVAGDEQEDSGHDTISNRDSYSDCNSNRNSIASFTSICSSQCSSYFHSDEMDSGDELPLSVRISHDKQDKIHSCLEHLFSQVDSITNLLKGQAVVRAFDQTKYLTPGRGLQEFQQEMEPKLSCPKRLRLHIKQDPWNLPSSVRTLAQNIRKFVEEVKCRLLLALLEYSDSETQLRRDMVFCQTLVATVCAFSEQLMAALNQMFDNSKENEMETWEASRRWLDQIANAGVLFHFQSLLSPNLTDEQAMLEDTLVALFDLEKVSFYFKPSEEEPLVANVPLTYQAEGSRQALKVYFYIDSYHFEQLPQRLKNGGGFKIHPVLFAQALESMEGYYYRDNVSVEEFQAQINAASLEKVKQYNQKLRAFYLDKSNSPPNSTSKAAYVDKLMRPLNALDELYRLVASFIRSKRTAACANTACSASGVGLLSVSSELCNRLGACHIIMCSSGVHRCTLSVTLEQAIILARSHGLPPRYIMQATDVMRKQGARVQNTAKNLGVRDRTPQSAPRLYKLCEPPPPAGEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
138 | Ubiquitination | KLLLELNKIRTIRTF HHHHHHHCHHHHHHH | 46.30 | - | |
215 | Ubiquitination | CSNINEAKRQMEKLE HCCHHHHHHHHHHHH | 36.66 | 29967540 | |
349 | Ubiquitination | MAKTPEEKHEWFEAI EECCHHHHHHHHHHH | 45.20 | 29967540 | |
374 | Phosphorylation | KLGMEQDTWVMISEQ CCCCCCCEEEEEEHH | 21.47 | 24144214 | |
379 | Phosphorylation | QDTWVMISEQGEKLY CCEEEEEEHHHHHHH | 13.03 | 24144214 | |
386 | Phosphorylation | SEQGEKLYKMMCRQG EHHHHHHHHHHHHCC | 14.12 | - | |
460 | Phosphorylation | FKPEQMLYRFRYDDG CCHHHEEEEEECCCC | 11.45 | 26074081 | |
464 | Phosphorylation | QMLYRFRYDDGTFYP HEEEEEECCCCCEEC | 18.70 | 26074081 | |
468 | Phosphorylation | RFRYDDGTFYPRNEM EEECCCCCEECCHHH | 27.30 | 26074081 | |
470 | Phosphorylation | RYDDGTFYPRNEMQD ECCCCCEECCHHHHH | 10.91 | 26074081 | |
480 | Phosphorylation | NEMQDVISKGVRLYC HHHHHHHHHHHHHHH | 24.17 | - | |
592 | Ubiquitination | VVENVIAKSLLIKSN HHHHHHHHHHEEECC | 30.43 | - | |
597 | Ubiquitination | IAKSLLIKSNEGSYG HHHHHEEECCCCCCC | 47.39 | 29967540 | |
623 | Phosphorylation | IKLVEKGSNAEMAGM EEEEECCCCHHHCCC | 43.89 | 23186163 | |
673 | Ubiquitination | LRVLVSTKPRETVKI EEEEEECCCCCEEEC | 34.27 | - | |
679 | Ubiquitination | TKPRETVKIPDSADG CCCCCEEECCCCCCC | 56.81 | - | |
901 | Phosphorylation | EHLCQRISSYKKFSR HHHHHHHHHHHHHHH | 29.79 | 24719451 | |
903 | Phosphorylation | LCQRISSYKKFSRVL HHHHHHHHHHHHHHH | 16.06 | 24719451 | |
907 | Phosphorylation | ISSYKKFSRVLKNRA HHHHHHHHHHHHHCC | 30.29 | 24719451 | |
946 | Phosphorylation | HVNVMEVSYPKTSTS EEEEEEEECCCCCCC | 23.55 | 24719451 | |
952 | Phosphorylation | VSYPKTSTSLGSAFG EECCCCCCCHHHHHC | 32.95 | - | |
953 | Phosphorylation | SYPKTSTSLGSAFGV ECCCCCCCHHHHHCC | 30.42 | - | |
964 | Phosphorylation | AFGVQLDSRKHNSHD HHCCCCCCCCCCCCC | 52.39 | - | |
1013 | Phosphorylation | QDGHGLRYLLKEEDL CCCCHHHHHHHHHHC | 22.79 | - | |
1022 | Phosphorylation | LKEEDLETQDIYQKL HHHHHCCHHHHHHHH | 38.55 | - | |
1026 | Phosphorylation | DLETQDIYQKLLGKL HCCHHHHHHHHHHHH | 14.11 | - | |
1052 | Phosphorylation | CQIDDLLSSITYSPK HCHHHHHHHCCCCCC | 27.30 | 27251275 | |
1053 | Phosphorylation | QIDDLLSSITYSPKL CHHHHHHHCCCCCCC | 20.94 | 27251275 | |
1055 | Phosphorylation | DDLLSSITYSPKLER HHHHHHCCCCCCCCC | 21.64 | 27251275 | |
1057 | Phosphorylation | LLSSITYSPKLERKT HHHHCCCCCCCCCCC | 13.60 | 27251275 | |
1063 | Acetylation | YSPKLERKTSEGIIP CCCCCCCCCCCCCCC | 47.21 | 19822241 | |
1064 | Phosphorylation | SPKLERKTSEGIIPT CCCCCCCCCCCCCCC | 37.93 | 23403867 | |
1065 | Phosphorylation | PKLERKTSEGIIPTD CCCCCCCCCCCCCCC | 36.54 | 28857561 | |
1073 | Phosphorylation | EGIIPTDSDNEKGER CCCCCCCCCCCCCCC | 44.83 | 23403867 | |
1082 | Phosphorylation | NEKGERNSKRVCFNV CCCCCCCCCEEEEEE | 28.23 | 22210691 | |
1101 | Phosphorylation | QEDSGHDTISNRDSY CCCCCCCCCCCCCCC | 22.19 | 22210691 | |
1103 | Phosphorylation | DSGHDTISNRDSYSD CCCCCCCCCCCCCCC | 28.09 | 22210691 | |
1107 | Phosphorylation | DTISNRDSYSDCNSN CCCCCCCCCCCCCCC | 24.25 | - | |
1495 | Phosphorylation | SFIRSKRTAACANTA HHHHHCCCHHHHCCC | 23.49 | 22210691 | |
1501 | Phosphorylation | RTAACANTACSASGV CCHHHHCCCCCCCCC | 15.54 | 22210691 | |
1504 | Phosphorylation | ACANTACSASGVGLL HHHCCCCCCCCCCHH | 24.01 | 22210691 | |
1506 | Phosphorylation | ANTACSASGVGLLSV HCCCCCCCCCCHHHH | 20.09 | 22210691 | |
1514 | Phosphorylation | GVGLLSVSSELCNRL CCCHHHHCHHHHHHH | 18.08 | - | |
1551 | O-linked_Glycosylation | QAIILARSHGLPPRY HHHHHHHHCCCCHHH | 19.12 | 31492838 | |
1558 | Phosphorylation | SHGLPPRYIMQATDV HCCCCHHHHHHHHHH | 13.40 | 18083107 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PREX2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PREX2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MTOR_HUMAN | MTOR | physical | 17565979 | |
GNMT_HUMAN | GNMT | physical | 28205209 | |
HUWE1_HUMAN | HUWE1 | physical | 28205209 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...